28% of Adults, 9% of Teens Use Tobacco Products in U.S.

Share this content:
28% of Adults, 9% of Teens Use Tobacco Products in U.S.
28% of Adults, 9% of Teens Use Tobacco Products in U.S.

THURSDAY, Jan. 26, 2017 (HealthDay News) -- Despite the dangers, many American adults and teens still use tobacco products, according to a report published in the Jan. 26 issue of the New England Journal of Medicine.

Researchers looked at 45,971 people and found that 27.6 percent of American adults currently use some form of tobacco, while 8.9 percent of teens said they used tobacco in the past month. Tobacco products included cigarettes, electronic cigarettes, cigars, cigarillos, filtered cigars, pipe tobacco, hookahs, snus pouches, and other smokeless tobacco. Forty percent of tobacco users used more than one product, with cigarettes and e-cigarettes being the most common combination, the researchers said.

E-cigarettes trailed only cigarettes in popularity for both youths and adults, and hookah smoking was very high among 18- to 24-year-olds. Among adults, 22.5 percent smoked cigarettes and 6.7 percent of those smokers also used e-cigarettes. Among youths aged 12 to 17, 13.4 percent smoked regular cigarettes, while 10.7 percent used e-cigarettes as well, the researchers found.

"During this study, 28 percent of U.S. adults were current users of tobacco, and 9 percent of youths had used tobacco in the previous 30 days. Use of multiple products was common among tobacco users," the authors write. "These findings will serve as baseline data to examine between-person differences and within-person changes over time in the use of tobacco products."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »